Successful conservative management of campylobacter cholecystitis occurring post chemotherapy and rituximab: a rare disease entity.

Campylobacter jejuni is commonly associated with gastroenteritis, but extremely few reports worldwide link it acute cholecystitis. These infectious complications can assume menacing proportions in the immunocompromised and need careful management. We present a report of such a case from Australia, successfully managed conservatively, without surgery.